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1. ABSTRACT 
Cancer is a complex and multigenic disease, which is typically 
initiated by genetic mutations in tumor suppressor genes that 
regulate homeostatic mechanisms within cells. Oncogenic 
promoter mutations, like those involved in signal transduction 
pathways, also have the potential to induce cancer in an otherwise 
healthy organism. Transformation is highly dependent upon 
mutations to both tumor suppressor and oncogenes, as neither 
mutation is exclusive in its ability to generate malignant tumors. In 
the model organism, Drosophila melanogaster, I have generated 
metastatic cancer through the genetic effect of overactive Raf 
signaling, in conjugation with silencing selected tumor suppressor 
genes using RNA interference. Metastasis, the uncontrollable 
migration of cancer to non-adjacent areas within an organism, was 
analyzed in vivo, using Green Fluorescent Protein as an indicator 
for the presence of mutant tissue. Scribble (scrib) and Discs large 
(Dlg), two genes involved in cell polarity, demonstrated the 
highest incidence of metastatic cancer when silenced using RNAi. 
This novel preliminary screen exhibits the influential role of Raf 
signaling and cell polarity genes in generating metastatic cancer.  
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2. INTRODUCTION 
Cancer 
As the second leading cause of death in the United States, 
cancer has become a national as well as global pandemic (Cancer 
Facts & Figures, 2012). With more than 1,000,000 new national 
diagnoses and 500,000 plus cancer-related deaths expected to 
occur in 2012, this disease is aggressive and deadly at its worst 
(Cancer Facts & Figures, 2012). As such, more pressure is being 
placed upon researchers to discover the mechanisms that enable 
cancer to completely alter cellular behavior.  
A scientific breakthrough occurred when one researcher, 
Alfred Knudson, discovered a model to explain the development of 
cancer, which eventually became known as the “Two-Hit Theory 
of Cancer Causation” (Knudson’s ‘Two-Hit’ Theory of Cancer 
Causation). In this model Knudson states that in order for normal 
cells to transform into cancerous ones, two mutations must occur 
(Knudson’s ‘Two-Hit’ Theory of Cancer Causation). He argues 
that the first mutation is genetic, as one inherited chromosome 
becomes damaged at conception, birth, or a later stage in life 
(Knudson’s ‘Two-Hit’ Theory of Cancer Causation). When 
another mutation occurs to that same gene, a “second hit” occurs 
(Knudson’s ‘Two-Hit’ Theory of Cancer Causation). This hit, in 
concert with the first mutation, enables the transformation of 
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cancerous cells (Knudson’s ‘Two-Hit’ Theory of Cancer 
Causation).  
Mutations are able to occur through a variety of mechanisms, like 
subtle sequence changes, alterations in chromosome number, 
chromosome translocations, and gene amplifications (Lengauer, 
Kinzler, and Vogelstein, 1998). In many tumors there has also 
been a major loss or gain of chromosomes, resulting in different 
cancerous conditions (Lengauer, Kinzler, and Vogelstein, 1998). 
For instance in glioblastomas, there is a loss in chromosome 10, 
which inactivates Pten, a tumor suppressor gene (Lengauer, 
Kinzler, and Vogelstein, 1998).  
As such, the stability of tumors is indirectly related to the 
mutation prevalence among cells (Lengauer, Kinzler, and 
Vogelstein, 1998). Such instability can result from cellular 
environmental conditions, like in cell-cell interactions (Lengauer, 
Kinzler, and Vogelstein, 1998). As tumors develop from continual 
and uncontrollable cellular proliferation, they are able to be 
classified as benign or malignant (Understanding Cancer Series). 
This classification is dependent upon the invasiveness of tumors, 
or their ability to metastasize (Understanding Cancer Series). 
Localized tumors are unable to spread to new sites and, as such, 
are not considered invasive (Understanding Cancer Series). 
However, cancerous tumors are able to invade neighboring tissues 
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through metastasis, and even induce blood vessel growth nearby 
and within the tumor through angiogenesis (Understanding Cancer 
Series). As such, only malignant tumors are considered to be 
cancerous (Understanding Cancer Series).  
An in-depth study of malignant tumors has shown cancer to 
possess six fundamental traits: a “self-sufficiency in growth 
signals, insensitivity to growth-inhibitory (antigrowth) signals, 
evasion of programmed cell death (apoptosis), limitless replicative 
potential, sustained angiogenesis, and tissue invasion and 
metastasis” (Hanahan and Weinberg, 2000). My project 
specifically focuses on two of these fundamental traits – a self-
sufficiency in growth signals as well as tissue invasion and 
metastasis.  
Signaling Pathways 
Multiple regulatory systems in living organisms are 
controlled by signaling pathways, which influence cellular growth. 
These pathways consist of numerous proteins that are triggered by 
a signal, causing an appropriate response within the cell. Upon 
ligand reception, a chain reaction occurs so that each protein 
becomes activated by the previous protein, carrying the signal to 
the nucleus of the cell.  It is in the nucleus that gene expression is 
affected, causing for the cell to become changed.  
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Mitogenic growth signals are required for normal cells to 
change from a dormant state into one that is active and 
proliferative (Hanahan and Weinberg, 2000). As such, signaling 
molecules are necessary in order for cell growth to occur. Some 
oncogenes predispose cells to cancer by mimicking such signals, 
thereby altering cellular signaling pathways (Hanahan and 
Weinberg, 2000). GTPase signaling pathways are particularly 
interesting, as uncontrolled signaling leads to an increase in 
cellular proliferation and malignant transformation (Reuter, 
Morgan, and Bergmann, 2000).  
As such, these tumor cells exhibit a reduced dependency 
upon growth signaling in comparison to normal, healthy cells 
(Hanahan and Weinberg, 2000). Therefore, a signal is no longer 
required as the cell becomes completely independent of necessary 
growth signals.  This renders inactive such an important 
homeostatic mechanism in controlling normal cell-like behavior 
(Hanahan and Weinberg, 2000). In order to induce self-sufficient 
proliferation, cancerous cells synthesize growth-signaling factors 
causing a positive feedback-signaling loop within the cell 
(Hanahan and Weinberg, 2000). Cancerous cells also manipulate 
growth factor receptors, as these cell membrane receptors receive 
such growth signals, thereby affecting gene regulation within the 
cell. However, tumor cells cause overactivity in the tyrosine kinase 
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activity of growth factor receptors, as well as ligand independent 
signaling, causing a hypersensitivity to signaling in cancerous cells 
(Hanahan and Weinberg, 2000).   
When mutations like this lead to an overactive signaling 
pathway, proteins are continually active without any regulatory 
mechanism. As one of the defining traits of cancer, 
overproliferation allows cells to become limitless in their 
replicative potential. As such, mutated proteins involved in 
overactive signaling pathways are considered oncogenes, because 
these genes contribute to the initiation or progression of cancer 
(Hanahan and Weinberg, 2000). In fact, within stomach, brain, and 
breast tumors, the epidermal growth factor receptor has been 
proven to be upregulated, affecting the pathogenicity of these cells 
(Hanahan and Weinberg, 2000).  
Epidermal growth factor receptors, or EGFR’s, are 
responsible for initiating two important signaling pathways: the 
RAS-RAF-MAP kinase and the PDK1-AKT pathways (Benvenuti, 
et. al, 2012). Cancerous cells also possess different extracellular 
matrix receptors, or integrins, which promote pro-growth signals 
(Hanahan and Weinberg, 2000). Such integrins enable the 
overactivation of the RAS-RAF-MAPK pathway (Hanahan and 
Weinberg, 2000). 
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Although it is known that these signaling pathways, when 
overactive, promote overproliferation, these biological changes are 
not sufficient to actually cause cancer – only a predisposition to it. 
However, mutations that induce overproliferation can sometimes, 
in concert with other mutations, lead to metastasis.  
Metastasis 
Metastasis occurs when  tumourous cells migrate from one 
organ to another, non-adjacent organ (Understanding Cancer 
Series). The migration of cancer cells is able to occur through 
uncontrolled mitosis or by the blood stream and lymphatic system 
(Understanding Cancer Series). When cancerous cells move to a 
new location in the body due to metastasis, a secondary tumor, or 
metastatic site forms (Understanding Cancer Series). As previously 
noted, benign and malignant cancers differ in their ability to 
metastasize; metastasis is a hallmark of malignant cancer 
(Understanding Cancer Series).  
Neoplastic growth occurs as cells continue to grow in an 
uncontrollable manner, causing cells to begin to pile on top of one 
another (Basler, Toggwiler, Willecke, 2011). With constrained 
space for growth, cells begin to migrate into new areas and tissues, 
becoming cancerous (Basler, Toggwiler, Willecke, 2011). Unlike 
neoplastic growth, hyperplasia results only in the proliferation of 
non-metastatic cells (Halder and Mills, 2011). Accordingly, 
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mutations in neoplastic tumor suppressor genes contribute to the 
invasiveness of tumors (Halder and Mills, 2011). 
The ability of cancer to spread to ectopic locations occurs 
through mutations related to the regulation of cellular processes – 
particularly those involved in migration and cell-cell adhesion 
(Hanahan and Weinberg, 2000). Since multiple regulatory systems 
in living organisms are controlled by signaling pathways, it is no 
surprise that mutated signaling pathways have been known to 
contribute to cancer. However, both negative and positive 
regulatory processes are necessary in order to generate metastasis 
(Liotta, Steeg, and Stetler-Stevenson, 1991). 
Unrestrained growth is unable to individually initiate 
metastasis, as misregulation of motility and proteolysis is also 
required to induce tumor invasion (Liotta, Steeg, and Stetler-
Stevenson, 1991). Once invasion has occurred, cancerous cells 
must be able to “arrest at the distant vascular bed, extravasate into 
the target organ interstitium and parenchyma, and proliferate as a 
secondary colony” (Liotta, Steeg, and Stetler-Stevenson, 1991).  
Tumors exist as a subpopulation of cells with special 
characteristics; cells become metastatic as they migrate from the 
original tumor (Liotta, Steeg, and Stetler-Stevenson, 1991). 
Interestingly enough, it has been shown through the use of genetic 
 10
markers that this subpopulation dominates the growth of the 
primary tumor (Liotta, Steeg, and Stetler-Stevenson, 1991).  
However, in order for such subpopulations to form, cancerous cells 
must first pass through the basement membrane, a dense matrix 
that prevents cellular traversal (Liotta, Steeg, and Stetler-
Stevenson, 1991). Only through invasion of the basement 
membrane is metastases able to occur as cancerous cells enter the 
blood stream and lymphatics (Liotta, Steeg, and Stetler-Stevenson, 
1991). As such basement membrane degradation is a common 
feature among many carcinomas; this structure remains intact in 
benign tumors (Liotta, Steeg, and Stetler-Stevenson, 1991). As 
such, proteolysis, or the degradation of cellular proteins, is also a 
feature of metastasis (Liotta, Steeg, and Stetler-Stevenson, 1991). 
When proteolysis is coupled with motility, invasion is able to 
occur in cancerous cells allowing for the formation of metastatic 
sites (Liotta, Steeg, and Stetler-Stevenson, 1991). 
Drosophila melanogaster 
In determining the occurrence of metastasis, Drosophila 
melanogaster was used as my model organism. The use of this 
organism as a scientific model is very advantageous, due to the 
fly’s small size and genome, with highly conserved sequences 
shared between the fly and human population. 
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 With a genome consisting of 165 million base pairs, 4 
chromosomes, and about 14,000 genes, Drosophila genes have 
easily recognized human homologues (Twyman, 2002). As such, 
research performed using Drosophila is able to contribute to a 
general understanding of human diseases and disorders.  
Additionally, as a small organism, large numbers of 
Drosophila are easily maintained within vials and bottles. This 
allows for multiple experiments to occur in a research lab 
regardless of limited space. Drosophila also has a short life cycle, 
which allows for relatively quick results when inducing mutations 
within the fly. One generation of Drosophila takes approximately 
seven to eight days to reach maturity, transforming from an egg, to 
larvae, then pupae, and eventually a fly (See Figure 2.1). Within 
any given cross, pending it is at 25°C, progeny appears 
approximately ten days after crossing. By crossing flies of different 
genotypes, mutations are easily induced. 
As my project utilizes signaling pathways in order to cause 
malignancy, Drosophila was an extremely beneficial organism to 
use; many known components within signal transduction pathways 
were originally discovered using the fruit fly (Halder and Mills, 
2011). Through Drosophila, the flippase system was able to be 
utilized in order to create homozygous mutant cells, as similarly 
performed in  
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other Drosophila genetic screens (Halder and Mills, 2011). 
Multiple transgenic stocks have also been created carrying 
different genomes of silenced tumor suppressor genes, which were 
necessary for my experiment (Halder and Mills, 2011).  
In order to successfully model cancer, it is vital that 
specific, complex genotypes be created in groups of cells, and that 
their behavior properly followed (Halder and Mills, 2011). 
Drosophila not only allows for the creation of such genetically 
modified clones but also enables successful tracking through the 
use of the Flippase/FRT system (Halder and Mills, 2011). 
Project Overview 
In my Capstone Project I attempted to generate metastasis 
within Drosophila melanogaster by first combining Raf-activated 
and RNAi transgenes and then crossing them to an eye/antennal 
epithelium specific Gal4 driver line. This required me to generate a 
stable stock with an overactive RAS-RAF-MAPK signaling 
pathway by targeting the Raf protein. In the Raf gain of function 
mutation, the signaling pathway was manipulated so that the Raf 
protein was continually phosphorylated, causing for the pathway to 
become hyperactive. In order to create a stock of flies carrying this 
genotypic mutation, as well as balancers, multiple crosses were 
performed.  
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 Since tumorigenesis is multigenic by nature, metastasis 
could only potentially be induced by also silencing a tumor 
suppressor gene. A small preliminary screen was performed, in 
which a total of fifteen tumor suppressor genes were knocked 
down using an RNA interference mechanism. Flies carrying the 
genotype containing the silenced genes were mated to those with 
the hyperactive signaling pathway in order to induce cancer within 
the progeny. 
Theoretically, since the offspring of this cross were 
carrying both mutations, the formation of malignant, metastatic 
tumors was more likely in these flies than if their genome had 
consisted of only one mutation. As such, analysis of the offspring 
carrying the double mutation was compared to other progeny of the 
cross that carried only the RNAi or the oncogene. 
When studying the RafACT flies, it was expected that there 
would be an overgrowth, but no migration, of GFP positive cells. 
However, when analyzing the RafACT + gene X- (where gene ‘X’ is 
knocked out) flies, GFP positive cells will be detected at ectopic 
locations, whenever the RafACT and the knocked out gene  caused 
metastasis together. This stage in my project was important in 
determining if various interactions between overactive signaling 
pathways and specific genetic knockouts cause for cancerous cells 
to metastasize. 
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All larvae were analyzed in vivo using Green Fluorescent 
Protein as a marker, in order to determine the occurrence of 
metastasis. The FLP/FRT and UAS/Gal4 systems ensured that the 
green marker was localized within the developing eye epithelium 
of the fly, when visualized using the fluorescent microscope. As 
such, GFP was seen in ectopic locations, areas other than the eye 
discs, when malignant tumors formed.   
In conclusion, my Capstone Project allowed me to identify 
second site mutations that lead to metastasis. It also enabled me to 
perform research on a signaling pathway protein that had not 
previously received significant scientific attention in comparison to 
the protein Ras. Utilizing both mutations, I demonstrated the 
significance of this protein in causing malignancy, as well as the 
necessity of cell polarity genes in preventing the formation of 
malignant tumors.  
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3. METHODOLOGY 
Flipping 
Flies are maintained within plastic vials or plastic bottles 
dependent on the amount of flies in a particular cross or stock. 
Approximately 20 flies are maintained within vials, while a bottle 
can sustain more than double this amount. To ensure proper 
nutrient supply, flies are flipped regularly to new vials and bottles 
that contain a layer of fresh food- consisting of mainly water, 
dextrose, yeast, agar, and cornmeal. If less than 10 flies are 
transferred, certain precautions must be taken to verify the health 
of the stock. For instance, within any container there must be at 
least a 3:1 ratio of females to males, with greater than half of these 
flies appearing to be healthy. Three shakes of dry yeast should also 
be added to any new vial before transferring. The label from the 
old vial must also be transferred, with the new vial being dated as 
well. Rather than disposing of the old vial, it should be taped to the 
new transfer and placed back in the tray.   
Wet Yeast Paste 
If flies are particularly unhealthy, wet yeast paste can be 
added to a vial or bottle. Yeast paste is also reproductively 
advantageous, as it makes the food more appealing to the females, 
thereby increasing the likelihood of eggs being laid. Wet yeast 
paste is made by taking a relative amount of dry yeast and adding 
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it to a 15 ml tube. Slowly a very minute amount of water is added 
to the tube, just enough for the yeast to soak up the moisture. A 
spatula is then used to mix the ingredients. While continuing to 
stir, water is gradually added again until the mixture becomes a 
paste. Using the spatula, the desired amount of paste is placed into 
the vial or bottle by gently placing the substance onto the food and 
side of the container; the yeast paste is very lightly mixed with the 
food and spread in a line, a quarter-length, up one wall of the vial 
or bottle.  
Stocks  
Stocks are fly lines that are genetically stable through the 
use of balancers. Balancers ensure the desired genotype by 
“balancing” the stocks. The most effective balancers suppress 
genetic exchange along the total length of the chromosome 
(Greenspan, 2004). By suppressing crossing over of homologous 
chromosomes, balancers minimize the likelihood of genetic 
recombination. This is due to the fact that “only those adults 
doubly heterozygous for the balancer and the lethal-bearing 
homolog survive” (Greenspan, 2004). A fundamental trait of 
balancers is the presence of recessive lethal alleles and dominant 
visible markers, thus homozygous balancer combinations (See 
Figure 3.1) (Greenspan, 2004). Within my project, I used two  
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balancers on the third chromosome: TM6B and TM3. TM6B 
carries dominant Humeral (Hu) and Tubby (Tb) along with 
recessive ebony (e) (Greenspan, 2004). TM3 instead carries 
recessive ebony (e) in addition to Stubble (Sb) (Greenspan, 2004).   
Expansion 
Stocks must be expanded when many copies of the same 
stock are needed for a given experiment. First, flies are flipped to a 
new vial or bottle, where they must remain until eggs are visible on 
the surface of the food. This typically takes three days at room 
temperature. At this point, the adult flies are able to be transferred 
to another new vial or bottle. Transfers may properly continue, 
pending the adult flies are given enough time to seed with each 
transfer. Expansion should end when the necessary amount of flies 
for the stock is achieved or when the flies are no longer able to 
sufficiently lay eggs. This typically occurs five days after the first 
room temperature transfer. Vials are also able to expand into bottle 
stocks when there are at least 20 flies within a healthy vial. 
Bottlenecking 
Bottlenecking occurs, as a safety precaution, when only one 
set of the adult flies remains. It is safe to copy a stock when there 
is crawling larvae visible within the designated vial. At this point 
the adult flies can be transferred to a new vial with dry yeast, 
assuming that there are enough males and females. The new vial 
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should be labeled and dated appropriately. The old vial should be 
saved.  
Scientific Microscopy 
Stereomicroscope 
The stereomicroscope is used for sex and phenotypic 
separation, crossing procedures, virgin collection, and larval 
analysis. Light intensity is adjusted using the setting on the 
microscope base. Bulbs are also adjustable. The coarse knob is 
used to magnify the image, while the fine knob allows for 
focusing.  
Fluorescence Microscope 
Samples are analyzed for metastasis using the fluorescence 
microscope. When using this microscope, the differential 
interference contrast (DIC) light must be turned off. Next, the 
BINO/PHOTO filter must be removed. At this point the shutter can 
then be opened. The color filter should be adjusted appropriately, 
at FITC/CY2 to allow for GFP visualization. The coarse and fine 
knobs adjust the discernability of the image. Using the microscope, 
camera images are able to be obtained.   
Confocal Microscope 
Pictures of tissues are taken using the confocal microscope. 
The microscope, camera, and fluorescence box are turned on 
accordingly. The computer must also be running simultaneously, 
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so that the LAS AF program can be utilized. Once slides are 
loaded and clipped, the fifth icon down on the left-most side must 
be touched. The double arrow or single arrow are used to 
respectively move the stage up or down. Next the GFP 
fluorescence is turned on. The 10X objective is used to find the 
sample. Once the image is focused and centered, the stage must be 
brought down and a drop of immersion oil must be added to the 
slide. Switching to the 40X objective, the sample is refocused. 
Ensuring the strongest intensity of GFP, the confocal software is 
used to create an image of the sample.  
Crosses 
Punnett Square 
Before performing a cross, a punnett square is made to 
ensure that the desired progeny will result from mating. As 
demonstrated in Figure 3.1, two axes are drawn with the females 
shown horizontally and males vertically. In each sector of one axis, 
all possible alleles, which are genetically transferrable from the 
parent to offspring, are listed. Therefore each box of the diagram 
represents possible combinations of both male and female gametes. 
Each of these combinations signifies the possible genotypes of the 
offspring. As such, the construction of a punnett square is 
necessary in order to verify that the desired offspring is produced; 
it is also used to note the other possible genotypes that could result 
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from the mating. This allows for specific phenotypes to be selected 
for further crossing schemes or in the creation of stocks.  
Clearing 
Vials and bottles must be completely cleared before virgin 
collection occurs. When clearing a vial or bottle, all adult and non-
virgin flies are removed. Clearing is typically synonymous with 
transferring flies, as a new copy is made while the old is used for 
collection. However if there are enough copies, then removal 
occurs by turning the vial or bottle upside down onto a CO2 pad; 
the CO2 gauge level should not exceed to 10-20 ppm. These flies 
are disposed of in the fly morgue, a flask consisting of ethanol. If 
flies are still present in the container, then the same procedure can 
be repeated or a paintbrush can be used to push the remaining flies 
into the food.  
Virgin Collection 
The accuracy of a cross is dependent upon proper female 
virgin collection. On the first day of collection, the designated 
bottles are cleared and dry yeast is added to the container. A 
kimwipe is folded into half and gently pushed into the bottom of 
the food to increase the surface area for crawling larvae. Once all 
eclosed flies are emptied, the bottles are placed at room 
temperature. Six to seven hours later, flies are able to be scored on 
the basis of sex. Newly emerged virgin females are distinguishable 
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from adults by the presence of the meconium, a dark spot on the 
abdomen, formed by food eaten during the larval stage 
(Greenspan, 2004). Females are saved into vials with dry yeast; 
each vial is labeled with number of virgins, their genotype, and the 
date. Collection bottles should be double checked to make sure that 
no flies remain; these bottles are placed at 18°C overnight. 
Temperature affects the sexual maturity of flies: at 18°C flies take 
18 hours to mature, while at 25°C it only takes 8 hours. Therefore, 
it is important to collect before maturity is reached between each 
collecting period. As such, flies should be collected no later than 
18 hours after they are placed in the 18°C incubator overnight. 
Collection continues using the outlined procedure until all 
necessary virgins are obtained for crossing.  
Sex Scoring 
Distinguishing between males and females is crucial for 
crossing. Males have sex combs, a rounded abdomen, dark bristles 
on their genitalia, and dark coloring at the dorsal end of their 
abdomen. Females have a pointed abdomen with lighter 
pigmentation. Differences are distinguishable in Figure 3.2. 
Crossing 
When crossing, the following supplies are necessary: an 
uncapped tray of vials, yeast shaker, bag of cotton, and virgin 
female flies of the appropriate genotype. Virgin females are  
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anesthetized by CO2. Using a paintbrush, the necessary amount of 
virgins is added to empty vials containing dry yeast. As virgins are 
added to each individual vial, they are capped using cotton balls to 
ensure that no unwanted flies are able to enter the vial. The amount 
of vials and virgins necessary is dependent on the number of 
crosses performed. Once finished adding all virgin females, the 
cross must be completed by adding the appropriate male flies. 
Once these flies are obtained, they are also anesthetized using the 
CO2 apparatus. Although a maximum of 1 male per 7 females is 
sufficient for a cross, normally 2-3 males are used per 5 or more 
females. Crosses are completed once males and females have been 
added to the same vial. All vials must be labeled with the date, 
cross scheme, and number of males and females in each vial. Vials 
should be placed at the appropriate temperature.  
Maintenance of Crosses 
Cross vials are not able to be maintained using the same 
procedure as stock vials. Three days after a cross is performed, 
adults should be transferred to a new vial. This should resume at 
the end of days 4, 5, and 6, with adults being flipped to a new vial. 
This allows for a single cross to expand approximately five times. 
Special circumstances arise when there is a scarcity or abundance 
of flies; transfers can happen as early as day 2 if there is a surplus 
of flies or as late as day 5 if there are very few flies present. Vials 
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should be cleared of adult flies when pupae begin to appear, this 
typically occurs at day 6 or 7 for the original cross vial. In transfer 
vials, the first pupae will appear approximately five days after the 
transfer date.   
Phenotypic Scoring 
Phenotypic scoring is crucial when performing crosses or 
selecting specific progeny from a desired cross. At the larval stage, 
male and females are able to be distinguished by the presence of 
the male testes. The testes are detectable by a small, translucent 
circle near the posterior end of the male larvae. The TM6B marker 
is also able to be distinguished at the larval stage by the appearance 
of tubby larvae; these larvae are shorter and fatter than the wild 
type. In adult flies TM6B causes the humeral phenotype, as shown 
in Figure 3.3. Humeral flies have greater or less than 2 large 
bristles on their shoulder, where as wild-type phenotype consists of 
only 2 macrochaetes.  
Larval Dissection 
The following supplies are necessary for larval dissection: 
disposable transfer pipettes, a pair of forceps, glass 9-well plate, 
plastic 24-well plate, tissue baskets, vial of larvae, 1X PBS, and a 
dissecting pad. First, the glass wells in the 9-well plate are filled 
with 1X PBS using a disposable transfer pipette. Next, a drop of  
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1X PBS is added on the dissecting pad; each larval dissection 
requires a separate drop. Using a paintbrush, 10 larvae are removed 
from the vial and placed in a 1X PBS well. One larvae is 
transferred to the dissecting pad using the forceps. The dissecting 
pad is then placed under the light microscope in order to perform 
the dissection. When dissecting, both forceps should gently pinch 
some of the larval coating, with the forceps then being pulled in 
opposite directions; this removes the skin tissue of the larvae. This 
procedure is repeated until all skin is removed from the larvae, 
with the skin being disposed of in a designated 1X PBS droplet on 
the dissecting pad. After the skin is removed, unnecessary tissue 
must also be eliminated. Both forceps are used to remove all tissue 
except the ventral nerve cord, brain, antennal discs, eye discs, wing 
discs, and mouth hooks. Excess tissue is also discarded in a 
separate droplet. Once the sample is finished, it is transferred to a 
basket located in 1X PBS in the plastic 24 well-plate. The above 
procedure is repeated for all larvae, placing all finished samples in 
the same basket; larvae tissue with different genotypes should not 
be mixed. Once all tissue samples are obtained and placed in the 
basket, the basket is transferred to another well plate filled with 
PLP fixative. Tissues should be fixed in PLP for 15-20 minutes.  
After this time period has passed the tissue samples are able to be 
mounted. Dissection supplies are handled accordingly: transfer 
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pipettes are disposed of in the trash, the glass well plate and 
dissecting pad are  
washed with water followed by an ethanol wash, and 1X PBS is 
placed back in the 4°C fridge. Forceps are also cleaned with 
ethanol using a kimwipe, and the vial of larvae is placed back at 
the appropriate temperature. 
Imaginal Disc/Antibody Staining 
 When necessary, antibody staining occurs after larval 
dissection. After dissection, the tissue is fixed in PLP for 30 
minutes at room temperature. At this same temperature, these 
samples are washed for 5 minutes in 1X PBS and then twice in 1X 
PBT, also for 5 minutes each. The primary antibody is then able to 
be added at the appropriate dilution (in NGS/PBT). After this step, 
these samples must be placed on the shaker overnight, for at least 
10 hours, at 4˚C. The following morning, the well plate and 
baskets are moved to room temperature, where the tissue is washed 
in PBT, 3 times for 10 minutes each. Samples are washed for 
another 3 cycles at 10 minutes each, in NGS/PBT. The secondary 
antibody is then added in a 1:200 dilution (in NGS/PBT). These 
samples are shaken again for 2 hours, at room temperature. Wash 
cycles are then repeated at room temperature: washed in PBT 3 
times for 10 minutes each and in PBS at 10 minutes each. Samples 
are then able to be mounted using mounting solution.  
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Mounting 
Tissue samples are mounted on slides following dissection. 
In order to mount the following supplies are required: mounting 
solution, slides, cover slips, 1X PBS, disposable transfer pipettes, 
and forceps. Before mounting it is necessary that slides are labeled 
with the name of the sample being mounted, amount of samples 
mounted, date, and initials. After labeling, one drop of 1X PBS is 
added towards the end of the slide using a disposable transfer 
pipette. The designated tissue to be mounted is placed within this 
drop. Under the light microscope, the tissue is cleaned using a pair 
of forceps; cleaning separates the tissues just enough so that they 
can be discerned easily when mounted. Once the tissue is prepared, 
one drop of mounting solution is added to the center of the slide 
using a new transfer pipette. The prepped tissue is transferred to 
the mounting solution and arranged accordingly. This procedure is 
repeated until all tissue samples are added to the slide, with each 
slide typically containing five samples. Once all samples are in the 
mounting solution, a kimwipe is used to remove the drop of 1X 
PBS. A coverslip is then gently placed over the mounting solution. 
After a few minutes of drying, the coverslip is sealed using nail 
polish, by brushing along all four edges of the square.  
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Solutions  
1XPBS 
In vitro and in vivo larval analysis is performed in 1X PBS. 
To make 1 L of PBS, 10 ml of 10X PBS is mixed with 90 ml of 
Millipore water. 
1X PBT 
 This solution is made by adding 1500 µl of 10% Triton 
(1ml of Triton + 9ml of Millipore water) and 50 ml PBS.  
NGS/PBT 
 This solution is necessary for the antibody staining 
procedure, mixing: 1 ml of 100% NGS and 600 µl 10% Triton. 
Using 1X PBS, this solution is then brought to 20 ml.  
Mounting Solution 
Mounting solution is required in order to preserve tissue 
samples on slides: 0.40 g of n-propyl gallate, 800 µl of 10X PBS, 2 
ml of enzyme-grade glycerol, 1.2 ml of H20 are combined into a 15 
ml tube. The tube is then vortex in order to ensure that the solution 
is thoroughly mixed. Mounting solution is stored at 4°C. 
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4. RESULTS AND DISCUSSION 
Induced Mutations 
Raf
ACT
 
An overactive RAS-RAF-MAPK signaling pathway was 
induced in order to induce the first mutation within Drosophila. 
Within this signaling pathway a signal is received by EGFR, which 
triggers the action of Ras, a small G-protein (Benvenuti, et. al, 
2012). G-proteins, or GTP-hydrolases, are extremely important 
within this pathway as they enable activation through intermittent 
conformational changes upon binding to guanosine diphosphate, 
GDP, and guanosine triphosphate, GTP (Reuter, Morgan, and 
Bergmann, 2000). When GTP-bound, Ras becomes activated from 
the protein’s dormant, GDP-bound state (Reuter, Morgan, and 
Bergmann, 2000). Guanine nucleotide exchange factors, like SOS, 
serve as regulatory proteins to control the cycling rate of Ras 
activation through GTP and GDP (Reuter, Morgan, and Bergmann, 
2000). SOS stimulates Ras by enabling the dissociation of GDP, 
thereby allowing for GTP incorporation (Reuter, Morgan, and 
Bergmann, 2000).   
When GTP bound, Ras activates an effector protein kinase 
Raf, which initiates the mitogen-activated-protein kinase cascade 
through phosphorylation (See Figure 4.1) (Benvenuti, et. al, 2012).  
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The intrinsic regulatory mechanism of this signaling pathway is 
extremely crucial in healthy cells, since hyperactive RAS-RAF-
MAPK pathways have been proven to be present in 25% of human 
tumors (Hanahan and Weinberg, 2000). The presence of Ras 
oncogenes have also been confirmed in approximately half of 
human colon carcinomas (Hanahan and Weinberg, 2000). In these 
tumors, the Ras protein is mutated so that mitogenic growth signals 
are continually released, causing habitual cellular stimulation 
(Hanahan and Weinberg, 2000).  
Within my project, I targeted the Raf protein in order to 
cause overactivity of the RAS-RAF-MAPK pathway. As shown in 
Figure 4.1, Ras triggers multiple pathways by potentially 
phosphorylating RalGEF, PI3K, or Raf (Reuter, Morgan and 
Bergmann, 2000). Hyperactivity in both the RAS-RAF-MAPK and 
PI3K pathways have shown to be correlated with tumorigenesis, 
however only RAF/MAPK pathway overactivity induces 
metastasis (Janda, et al., 2002). This pathway is also known to be 
required for initiating transforming growth factor ß epithelial 
mesenchymal transition, or TGFß EMT (Janda, et al., 2002). EMT 
is “characterized by spindle-like cell morphology, loss of epithelia 
markers, and induction of mesenchymal markers” (Janda, et al., 
2002). Oncogenic Raf has also been shown to prevent TGFß-
induced apoptosis as well as create more contact between cells and 
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their migration (Janda, et al., 2002). As such, I decided to use a 
mutation of Raf that led to hyperactivation of the RAS-RAF-
MAPK pathway in order generate malignant tumors within the fly.  
RNAi Mechanism 
RNA interference was used as a technique for silencing 
targeted tumor suppressor genes, inducing a second mutation 
within my organism of study (See Figure 4.2). This method utilizes 
transgenes that encode specific RNAi sequences, which are 
produced upon transcription of the transgene. Silencing occurs at 
the post-transcriptional level, interfering with DNA regulation of 
these specific genes (Hannon, 2002). Double stranded RNA 
initiates this process upon recognition by the Dicer enzyme 
(Hannon, 2002). As part of the RNase III ribonuclease family of 
enzymes, Dicer possess two dicer molecules and five domains that 
are able to process dsRNA, producing small interfering RNA’s 
(Hannon, 2002).  These siRNA’s are approximately 22 nucleotides 
long due to an inactive site on the Dicer enzyme, which shifts the 
targeted activity of this enzyme to Dicer family members (Hannon, 
2002). Small interfering RNA’s are received by the RNA-induced 
silencing complex, which serve as effector nucleases (Hannon, 
2002). RISC effectively unwinds the siRNA’s through an ATP-
dependent process, thereby transforming from a zymogen into an 
active  
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complex (Hannon, 2002). When activated, the siRNA’s guide the 
RISC complex to homologous substrates, with significant 
complementation of sequences between the siRNA and mRNA 
target (Hannon, 2002). Upon recognition, RISC-associated 
nucleases cleave these mRNA substrates at specific sites thereby 
inhibiting effective translation (Hannon, 2002). As such, these 
steps characterize RNAi: “assembly of siRNA with the RNA-
induced silencing complex, activation of the RISC, target 
recognition and target cleavage” (Reynolds, et al, 2003). 
By hindering this translational machinery, RNAi was 
utilized within my Capstone Project to prevent protein synthesis of 
specific tumor suppressor genes: dsh, dlg, ce, dsh, arm, shg, skpA, 
ups7, vps25, scrib, cdc2, pten, cdc27, UASyki, cdc37, and tsc1. It 
was expected that by silencing these genes that interfere with 
tumor formation, the development of cancerous cells would be 
stimulated. As such, this secondary mutation, in conjugation with 
hyperactive Raf signaling, would theoretically lead to the 
formation of malignant tumors in Drosophila melanogaster.  
Identification of Ectopic-GFP Cells 
FLP/FRT and UAS/Gal4 Systems 
Both the FLP/FRT and UAS/Gal4 systems were vital in 
targeting and identifying the presence of mutant cells. In order to 
localize cancerous cells in the eye of Drosophila and tag these 
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cells using Green Fluorescent Protein, the following stock was 
used: ey-Flip; Act>IC>Gal4 UAS-GFP; UAS-dicer2.  
The UAS/Gal4 system utilizes two components: a Gal4 
driver and a Gal4 responsive UAS expression vector (Rorth, 1998). 
When in the presence of Gal4, binding sites on the Upstream 
Activator Sequence become occupied, thereby driving gene 
expression (Rorth, 1998). Therefore, the presence of Gal4 is 
necessary in order to activate the transcription of GFP (to mark the 
cells) and Dicer 2 (an endonuclease that enhances the effectiveness 
of RNAi) sequences (Duffy, 2002). As such, the absence of Gal4 
expression effectively silences these UAS controlled reporter 
genes (Duffy, 2002). In addition, in the progeny, the UAS-RNAi 
transgene is also activated in the same cells, such that siRNAs are 
generated and silence the targeted gene.  
The expression of a reporter gene is able to be influenced 
by cellular localization, timing, sensitivity, and protein and mRNA 
stability (Duffy, 2002). Most noticeably, Gal4 expression is 
affected by temperature, as minimal activity occurs below 16˚C 
(Duffy, 2002). At 29˚C, Gal4 activity is maximal with few effects 
on fertility and viability (Duffy, 2002).  
Temporal and spatial expression of targeted genes is also 
regulated by the FLP/FRT system, as it directly affects Gal4 
expression. The flippase recombinant enzyme, FLP, allows for 
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genetic recombination between the Flippase Recognition Target 
sites (Duffy, 2002). As shown in Figure 4.3, the FRT sites 
effectively flank the interruption cassette, which is responsible for  
terminating transcription (Duffy, 2002). As the interruption 
cassette is located between the promoter and Gal4 gene, its 
presence effectively prohibits Gal4 expression (Duffy, 2002). 
However, ey-Flip allows for the FLP enzyme to remove the 
cassette, thereby promoting tissue-specific regulation within the 
Drosophila eye tissue (Duffy, 2002).  Since the ey-Flip is only 
expressed in the developing eye-antennal tissue, the flippase 
localizes GFP within the eye; therefore, metastasis is determined 
based on the presence of ectopic GFP cells in secondary sites, 
those other than the eye antennal epithelium. These systems 
therefore effectively determine the loss of function phenotypes that 
result from silencing tumor suppressor genes.  
Experiments  
Ras
ACT
 and Raf
ACT
 Preliminary Test 
Before beginning my experimental project, it was crucial to 
determine which Ras and Raf lines would be the most effective in 
generating metastasis. Therefore, a preliminary test was performed, 
in which each available Ras and Raf lines within the lab were 
crossed to the ey-Flip; Act>IC>Gal4 UAS-GFP; UAS-dicer2 stock 
(See Figure 4.4). In the first cross, the ey-Flip line was crossed to  
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itself in order to induce double GFP expression. As such, this cross 
showed the strongest GFP expression, so that all normally 
expected areas of expression could be noted. Single GFP 
expression was observed in the second cross, as this cross showed 
comparable expression to that which was expected in the 
experimental RNAi project. ey-Flip was also crossed to two Raf 
lines: P{w[+mc]=UAS-hRaf1.gof}ra2. y[1]w[*], encoding an 
activated form of human Raf, and w;FRT82B UAS-RafACT, 
encoding the activated fly Raf. A total of three Ras lines, all 
encoding activated fly Raf1, were also tested: w; FRT40A UAS-
Rasv12/CyO; UAS-Rasv12 on 3, and w; UAS-Rasv12/CyO; 
FRT82B/TM6B.  
As indicated in Figure 4.5, each of the Ras lines produced 
greater overgrowth in the eye disc, in comparison to Raf. There 
were also more secondary GFP expressing sites in Ras than in Raf, 
displayed in Figure 4.6 as well. Although H-rafACT (gof) was the 
only one of these lines to not show extra visualization systems, this 
cross also produced the fewest progeny resulting in a smaller total 
sample size in comparison to the other crosses. Ectopic GFP 
typically appeared in the gut of the Rasv12 progeny, while RafACT 
(FRT82B) secondary GFP expression was visible in the haltere 
discs. Additionally, adult viability was greatest for 2X GFP and 1X 
GFP expression, but somewhat diminished in the RafACT progeny  
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and most severly affected in Rasv12 progeny. All Raf and Ras 
crosses showed neuronal differentiation when stained with CY3.  
The results of this screen indicated that the w; UAS-
Rasv12/CyO; FRT82B/TM6B line should be used as the 
representative line for Ras in the experimental RNAi project. This 
decision was due to the fact that Rasv12 (FRT82B) demonstrated 
the greatest likelihood of producing secondary sites, as extreme  
overproliferation was consistently observed during three separate 
trials of testing.  
According to this screen, the w; FRT82B UAS-RafACT line 
would have been ideal to use for the experimental screen, as this 
was the only Raf line that considerably proved to generate larger 
overgrowths. However, in designing a screen to test for metastatic 
cancer, it was more beneficial for overactive Raf to be carried on 
the first chromosome, rather than the third. In addition, the use of 
human Raf gene rather than fly Ras was appealing because any 
observed genetic interaction would directly apply to the protein 
found in human cancers. As such, the P{w[+mc]=UAS-
hRaf1.gof}ra2. y[1]w[*] stock was bottlenecked in order to 
increase the viability and health of these flies.  
Generating Ras
ACT
 and Raf
ACT
 
Once it was determined which Ras and Raf lines would be 
used for the experimental RNAi screen, it was necessary to create 
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stable, healthy stocks containing these genotypes in order to test 
for metastasis.  The crossing schematic for Ras was designed, 
incorporating the Ras genotype with both the TM3 and TM6B 
markers, as shown in Figure 4.7, Rather than using the initial Ras 
stock, it was necessary to create the new w; UAS-RASv12; 
TM3/TM6B stock due to the presence of these markers. In 
performing the experimental crosses, both TM3 and TM6B were 
necessary in order to ensure that the final experimental flies were 
carrying the correct genotype, by being scored for, and against, 
both of these markers. 
The first two crosses in the Ras schematic were performed 
at the same time, as the female offspring of the first cross (w; 
UAS-RASv12/CyOarmGFP; FRT82B) and male progeny of the 
second (w; UAS-Rasv12/CyO; FRT82B/TM6B) were then crossed 
together to generate the final desired genotype (w; UAS-Rasv12; 
TM3/TM6B).  
In order to produce this final stock, it was necessary that 
the CyO marker was scored against, as the absence of curly wings 
ensured the presence of homozygous Ras on the second 
chromosome in the final line. Similarly, the presence of the TM3 
and TM6B makers confirmed the absence of FRT82B in the 
ultimate stock, which would have interfered with a necessary 
mechanism in the experimental cross.  
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As the line of Raf became more stable through the bottlenecking 
process, the P{w[+mc]=UAS-hRaf1.gof}ra2. y[1]w[*] line was 
also able to be used in order to generate the appropriate stock for 
the experimental screen (Figure 4.8). First, this stock was crossed 
against a line carrying both the TM3 and TIM6B markers; two 
different males were collected from this cross, with each carrying 
one of these markers and the overactive Raf genotype. Males 
carrying each of these genotypes were crossed back to the original 
stock in order to produce females that were homozygous for 
hyperactive Raf, whereas this was not genetically possible in the 
first cross. These progeny were crossed so that a stock completely 
homozygous for Raf could be produced, also carrying both the 
TM3 and TM6B phenotypic markers.  
However, the Raf line also demonstrated an extreme 
weakness in the presence of both balancers. In order to ensure the 
viability of the stock, a bottle was made that contained flies that 
were either TM3 or wild type over TM6B. It was necessary to  
retain the TM6B marker, as this marker allows for larval scoring, 
which was necessary in the experimental cross. This bottle was 
also bottlenecked and expanded; the UAS-RafACT; III/TM6B 
genotype became more dominant over time due to an increased 
viability in these flies, in comparison to those flies carrying both 
markers. 
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Although the intention was to use both of the newly 
generated stocks in the experimental screens, the w; UAS-Rasv12; 
TM3/TM6B stock could not be utilized. Despite using robust 
crosses, very few flies carrying this genotype were produced, with 
even a fewer amount of healthy flies. Although similar results 
occurred in creating the Raf stock, a greater among of healthy, 
viable flies were produced in comparison to Ras. As such, the Raf 
line was able to be easily bottlenecked for the final experiment, 
while Ras was not. These flies also exhibited an extreme 
sensitivity to temperature, as viability drastically decreased with an 
increase in the environmental temperature. After discovering this 
fact, these flies were maintained at 18˚C throughout the remainder 
of the bottlenecking process. However, even in an optimal 
temperature environment, these flies were too weak to survive, let 
alone be able to be used for the experimental screen.  
Preliminary Screen 
The main purpose of the first preliminary screen was to test 
the effectiveness of the newly created Raf stock in generating 
metastasis. Although the final Ras stock was unable to be used, the 
experimental screen was still designed and implemented using 
UAS-RafACT; III/TM6B as shown in Figure 4.9. These flies were 
mated to males that carried UAS-RNAi transgenes that when 
activated would silence tumor suppressor loci by RNAi. Male  
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offspring were then mated to females of the ey-Flip; Act>IC>Gal4 
UAS-GFP; UAS-dicer2 genotype. While the first cross combined 
the two mutations-inducing transgenes within the fly, hyperactive 
Raf and the tumor suppressor gene RNAi, the second ensured the 
localization and visualization of cancerous cells using Green 
Fluorescent Protein.  
 In the final cross, four types of progeny were produced, 
with only one containing the desired genotype, ey-Flip/UAS-
RafACT/Actin>IC>Gal4 UAS-GFP; UAS-dicer2/UAS-RNAi 
(Figure 4.10). The other three possible genotypic offspring served 
as controls with either the tumor suppressor gene being present or 
hyperactive Raf being absent, or with one type of progeny carrying 
neither. Only the ey-Flip/UAS-RafACT; Act>IC>Gal4 UAS-GFP; 
UAS-dicer2/TM6B progeny were scored, as these determined the 
phenotype of hyperactive Raf.  
 A subset of  RNAi genes were selected for this screen as 
well, based on their suspected involvement in metastasis 
development and their proven effectiveness in down regulating the 
targeted gene based on mutant effects induced in the eye: vsp25, 
ce, dsh, arm, shg, skpA, ups7, and dlg (Figure 4.11). Larval 
analysis for ups7 and dlg showed the presence of ectopic cells at 
both the anterior and posterior, at a respective ratio of 1:7 and 4:11.  
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As shown in Figure 4.12. GFP positive cells were observed in the 
larval midsection for two dlg experimental samples. Two other dlg 
samples (not shown) expressed GFP in the anterior of larvae, with 
one of the samples also showing ectopic expression in the mid-
section as well. Only one (out of seven) Ups7 larvae was 
metastatic, expressing green fluorescent protein at the anterior. All 
controls expressed green fluorescent protein within the eye 
antennal epithelium and part of the brain lobes, as expected.   
 Pilot Screen 
 After it was confirmed that silenced tumor suppressor 
genes, in combination with RafACT, were able to induce metastasis, 
a larger pilot screen was performed. Since dlg and ups7 generated 
ectopic GFP cells in the preliminary screen, these genes were re-
tested in the secondary screen. Eight other genes were selected 
based on previous research performed, indicating the involvement 
of these genes in the regulatory processes relating to metastasis: 
scrib, pten, uasyki, dsh, cdc27, cdc2, cdc37, and tsc1 (Figure 
4.13). Specifically, extensive research has been done on the 
knockdown effects of scrib, dlg, and dsh in conjugation with 
hyperactive Ras, in causing metastatic behavior. Therefore, it was 
expected that the silencing of these genes would induce the 
presence of ectopic cells when combined with overactive Raf. 
These genes did in fact advance the formation of malignant  
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cancers; pten and UAS-yki, which caused for the overexpression 
instead of knockdown of the Yki protein, also showed similar 
results. 
 As seen in Figures 4.14/4.15/4.16, the suppression of scrib 
and dlg produced the greatest metastatic rate; suppression of pten 
or dsh and the overexpression of yki were only able to trigger 
cancer less robustly, at rates of 5.6%, 5.6%, and 7.1% respectively. 
Both tsc1 and cdc27 had less than a 4% chance of showing 
metastasis. Within the controls tested, ectopic cells were present in 
one larvae, generating a 0.5% metastatic rate for the total sample 
size (Figure 4.17).  
 In order to determine the relationship between larval 
development and metastatic rate, experimental samples were re-
scored as pupae (Figures 4.18 and 4.19). While each of these 
samples contained the desired genotype, none of these larvae 
contained ectopic GFP cells as larvae. However, these samples 
exhibited a 7.1% chance of  forming malignant tumors at a later 
stage in development. These samples also consistently exhibited 
tissue shrinkage from the pupal encasing, interfering with eclosion 
and thereby causing death. As such, the development of cancer in 
Drosophila mirrors the progression of the disease within humans, 
strengthening in development over time.  
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 However, some larvae also exhibited no GFP expression; 
this was most likely due to interference by the RNAi mechanism; 
RNAi expressing cells possibly may have died thereby causing an 
absence of GFP expression. It should also be noted that control 
samples containing RafACT, which did not previously contain 
ectopic GFP cells, later indicated metastasis with a 24% metastatic 
rate. As demonstrated in the Ras vs. Raf screen, hyperactive 
signaling sometimes resulted in ectopic GFP expression. While 
this result was not expected, its occurrence is most likely 
correlated with inefficiencies in the FLP/FRT and UAS/Gal4 
systems. An inefficient flippase enzyme would have been 
unsuccessful in its role to localize GFP expression to the epithelial 
tissue of larvae.  
 Larvae of the original ey-Flip; Act>IC> Gal4 UAS-GFP; 
UAS-dicer2 were analyzed under the fluorescence microscope in 
order to test this theory. Some larvae exhibited GFP expression 
throughout all tissues, thereby substantiating the imperfections 
within the ey-Flip stock. 
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5. FUTURE DIRECTION 
Important Cellular Processes 
 As noted by the experimental results, suppressed scribble 
(scrib) and discs large (dlg) produced the most significant rate of 
metastasis, in concert with hyperactive Raf. Extensive research has 
proven both of these genes to be involved in the processes of 
cellular polarity; mutations in both scrib and dlg have been known 
to cause overgrowth phenotypes and defects in epithelial 
monolayer formation (Pagliarini, 2003). It has been suggested that 
the involvement of these genes in “the abrogation of inter-cellular 
junctions or the mislocalization of plasma membrane-targeted 
signaling molecules” prevents the formation of NONinvasive 
tumors (Pagliarini, 2003). Likewise, the conserved scaffolding 
protein that is encoded by scrib and dlg is also necessary in 
maintaining cell polarity (Halder and Mills, 2011). Therefore the 
existence of these genes within the Drosophila genotype is 
necessary in order to ensure proper apical-basal cell polarity and 
consequently normal, healthy epithelial cells (Halder and Mills, 
2011).  
Future Connections 
 By identifying the cellular processes that are related to 
cancer, like cell polarity and epithelial monolayer formation, more 
advances can be made in the field of oncology. By understanding 
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such connections, the nature of cancer can be further questioned 
through analyzing the initiating effects of various molecular and 
cellular processes in cancer development. For instance, it is quite 
possible that the characteristics of this disease could vary based on 
whether suppression occurs in cell polarity or vesicular trafficking 
proteins. By identifying the biological role of specific proteins, 
questions like these can be addressed and the inherent qualities of 
cancer can be further understood.   
Development of Screen 
 Based on the pilot screen, a larger-scale screen could be 
generated to further test the metastatic effects of UAS-RafACT; 
III/TM6B. Tumor suppression genes that consistently lead to green 
offsites could also be analyzed using different hyperactive 
signaling pathways, like with Notch or EGFR. By comparatively 
studying the interaction of these pathways with the mutated genes, 
it can be determined if all tumor cells are inherently the same or 
not in terms of which second site hits best promote metastasis.  
 As such, the newly generated Raf stock, from my Capstone, 
could be useful in determining the roles and regulatory processes 
of specific genes, as well as helping researchers to further 
understand malignant growth.  
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7. SUMMARY 
Cancer is an extremely complex disease, as tumorigenesis 
requires mutations in tumor suppressor and oncogenes (Basler, 
Toggwiler, and Willecke). However, over the years, oncogenic 
research has proved there to be six fundamental traits of cancer: a 
“self-sufficiency in growth signals, insensitivity to growth-
inhibitory (antigrowth) signals, evasion of programmed cell death 
(apoptosis), limitless replicative potential, sustained angiogenesis, 
and tissue evasion and metastasis” (Hanahan and Weinberg). 
While each of these identified qualities contribute to the lethality 
of the disease, my Capstone project specifically focuses on the 
topic of tissue evasion and cancer metastasis. 
Both benign and malignant tumors possess the first five 
fundamental traits of cancer, only differing in their ability to evade 
tissues and thereby infect new areas of the body. Cancer is 
described as being benign when the disease is localized to a 
specific area within an organism, demonstrating no outward 
growth from the disease’s initial area of formation. In contrast, 
malignant cancer is extremely dangerous as it visibly moves to 
new locations within the body, creating metastatic sites.  
Metastatic sites form when an area that was previously 
unoccupied by cancerous cells, exhibits the presence of new, 
cancerous cells (Hanahan and Weinberg). By migrating from the 
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original location of the disease to a non-adjacent area within the 
body, cancerous cells cause for new sites to become infected by the 
disease (Hanahan and Weinberg). There are multiple mechanisms 
that enable such movement of cancerous cells, like uncontrolled 
mitosis or angiogenesis (Hanahan and Weinberg). Angiogenesis 
enables cancer cells to utilize the blood stream or lymphatics in 
order to metastasize, while mitosis refers to the uncontrollable 
division of cancerous cells (Hanahan and Weinberg). Both of these 
qualities are dependent upon the other fundamental traits of cancer.  
As proposed by Dr. Knudson, there is also a simplified 
model of the development of cancer termed the “two-hit” theory 
(Knudson’s ‘Two-Hit’ Theory of Cancer Causation). Knudson 
suggests that the causation of cancer is heavily based on multiple 
chromosomal mutations (Knudson’s ‘Two-Hit’ Theory of Cancer 
Causation). While the first “hit” makes an organism more 
susceptible to developing the disease, the second “hit” is most 
likely to cause for cancer (Knudson’s ‘Two-Hit’ Theory of Cancer 
Causation). This theory is reflected in my Capstone Project, as I 
utilized the effects of two separate mutations, in both tumor 
suppressor and oncogenes, as a leading cause to metastasis in 
Drosophila melanogaster. 
The first mutation in my experiment was in a specific 
signaling pathway, since overactive signal transduction pathways 
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have also been known to contribute to the formation of cancer. 
Within this pathway, a signal or ligand is received by a growth 
factor receptor, initiating an appropriate cellular response within 
the cell. Phosphorylation allows for the activation of proteins 
through the addition of a phosphate molecule, regulating the 
desired activation level within a pathway. As such, the behavior of 
overactive signaling pathways is as if the proteins within the 
transduction pathway are continually phosphorylated, or activated. 
Manipulation of signaling pathways can also mimic the effects of 
the constant presence of a ligand or signal, which would also cause 
for the pathway to be overactive.  
The pathway that I specifically manipulated was an MAPK 
signaling pathway called the RAS-RAF pathway (Research 
BRAF). In this pathway there are two types of protein kinases, Ras 
and Raf, which are responsible for relaying the extracellular signal 
within the cell (Research BRAF). Mutations to the RAS-RAF 
pathway can cause changes in cell differentiation, proliferation, 
and growth – three processes that this pathway is responsible in 
controlling for normal cell function (Research BRAF). In order to 
determine the most effective hyperactive Ras and Raf lines to use, 
each available stock was analyzed to distinguish which caused the 
greatest proliferation within larval eye tissues. Originally, two 
stable stocks for hyperactive Ras and Raf were created; however, 
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due to a substantial weakness in the Ras line, it was eliminated 
from the experimental project. Therefore, in my project, I used a 
Raf mutant protein in order to create a hyperactive GTPase 
signaling pathway within a specific line of flies.   
These tester flies were mated to a separate line of flies that 
carried a transgene with the ability to silence targeted genes, using 
RNA interference. By decreasing the activity of specific genes, 
RNA interference enabled me to create a second mutation in my 
project, causing the progeny flies to be more susceptible to 
developing cancer.  
The offspring carried a genome that had an overactive as 
well as a “knocked-out” gene and consequently were analyzed for 
the occurrence of metastasis. Analysis was possible due to the 
UAS/Gal-4 and FLP/FRT systems and by the presence of the 
protein marker, green fluorescent protein, which localized 
expression of GFP in the eye tissue of normal, or wild type, larvae. 
As such, the occurrence of metastasis was verified when GFP 
positive cells were detected in locations other than the developing 
head epithelium. 
Originally larvae were analyzed in vitro, however later the 
procedure changed to an in vivo approach due to a better 
visualization of metastasis within living, intact larvae. A 
preliminary screen was performed in order to test the effectiveness 
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of the final overactive Raf stock, by crossing this line of flies to a 
subset of genes: vps25, ce, dsh, arm, shg, skpA, ups7, and dlg. 
Ectopic behavior was observed in dlg and ups7; once it was 
confirmed that the newly constructed Raf line was able to induce 
metastasis, in conjugation with the suppression of specific genes, a 
pilot screen was designed. In this final screen a variety of genes 
were also tested including scrib, dlg, cdc2, pten, ups7, cdc27, 
UASyki, cdc37, tsc1, and dsh. Ectopic expression of GFP and the 
occurrence neoplastic growth was most significant in scrib and dlg.  
In the scientific community, extensive research has been 
performed on both scrib and dlg, using a mutant Ras protein. This 
research has indicated the biological processes of both scribble and 
discs large  to be involved in cell polarity (Pagliarini, 2003). 
Mutations in these genes also caused for defects in epithelial 
monolayer formation (Pagliarini, 2003). As such both cellular 
polarity and epithelial monolayer formation are critical in 
preventing the metastasis of cancer  (Pagliarini, 2003).  
In performing a novel screen, it was discovered that scrib and dlg, 
in combination with RAFACT, led to metastatic cancer. This 
indicates that an overactive Raf pathway, in conjugation with these 
silenced cell polarity genes, is also able to cause defects in the 
normal functioning of cells. As such, both of these mutations are 
necessary in order to induce metastatic behavior.  
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